Related references
Note: Only part of the references are listed.Remission and platelet responses with romiplostim in primary immune thrombocytopenia: final results from a phase 2 study
Adrian Newland et al.
BRITISH JOURNAL OF HAEMATOLOGY (2016)
Successful discontinuation of eltrombopag after complete remission in patients with primary immune thrombocytopenia
Tomas Jose Gonzalez-Lopez et al.
AMERICAN JOURNAL OF HEMATOLOGY (2015)
Sustained remission of chronic immune thrombocytopenia after discontinuation of treatment with thrombopoietin-receptor agonists in adults
Libor Cervinek et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2015)
Rituximab as second-line treatment for adult immune thrombocytopenia (the RITP trial): a multicentre, randomised, double-blind, placebo-controlled trial
Waleed Ghanima et al.
LANCET (2015)
A randomized trial of avatrombopag, an investigational thrombopoietin-receptor agonist, in persistent and chronic immune thrombocytopenia
James B. Bussel et al.
BLOOD (2014)
The temporary use of thrombopoietin-receptor agonists may induce a prolonged remission in adult chronic immune thrombocytopenia. Results of a French observational study
Matthieu Mahevas et al.
BRITISH JOURNAL OF HAEMATOLOGY (2014)
T cell immune abnormalities in immune thrombocytopenia
Xuebin Ji et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2014)
Safety and efficacy of eltrombopag for treatment of chronic immune thrombocytopenia: results of the long-term, open-label EXTEND study
Mansoor N. Saleh et al.
BLOOD (2013)
Long-term treatment with romiplostim in patients with chronic immune thrombocytopenia: safety and efficacy
David J. Kuter et al.
BRITISH JOURNAL OF HAEMATOLOGY (2013)
Sustained remissions of immune thrombocytopenia associated with the use of thrombopoietin receptor agonists
Bahareh Ghadaki et al.
TRANSFUSION (2013)
The scintigraphic index spleen/liver at 30 minutes predicts the success of splenectomy in persistent and chronic primary immune thrombocytopenia
Manel Roca et al.
AMERICAN JOURNAL OF HEMATOLOGY (2011)
The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia
Cindy Neunert et al.
BLOOD (2011)
Romiplostim for the treatment of chronic immune thrombocytopenia in adult Japanese patients: a double-blind, randomized Phase III clinical trial
Yukari Shirasugi et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2011)
Eltrombopag for management of chronic immune thrombocytopenia (RAISE): a 6-month, randomised, phase 3 study
Gregory Cheng et al.
LANCET (2011)
International consensus report on the investigation and management of primary immune thrombocytopenia
Drew Provan et al.
BLOOD (2010)
Autologous 111In-labelled platelet sequestration studies in patients with primary immune thrombocytopenia (ITP) prior to splenectomy: a report from the United Kingdom ITP Registry
Ameet Sarpatwari et al.
BRITISH JOURNAL OF HAEMATOLOGY (2010)
Treatment practices in adults with chronic immune thrombocytopenia - a European perspective
Francesco Rodeghiero et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2010)
Evidence-Based Mini-Review: Is Indium-Labeled Autologous Platelet Scanning Predictive of Response to Splenectomy in Patients With Chronic Immune Thrombocytopenia?
Adam Cuker et al.
HEMATOLOGY-AMERICAN SOCIETY HEMATOLOGY EDUCATION PROGRAM (2010)
Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group
Francesco Rodeghiero et al.
BLOOD (2009)
Epidemiology of immune thrombocytopenic purpura in the General Practice Research Database
W. Marieke Schoonen et al.
BRITISH JOURNAL OF HAEMATOLOGY (2009)
Characteristics of immune thrombocytopenic purpura: a guide for clinical practice
Drew Provan
EUROPEAN JOURNAL OF HAEMATOLOGY (2009)
Intravenous Immunoglobulin and Anti-RhD Therapy in the Management of Immune Thrombocytopenia
Nichola Cooper
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2009)
Effect of eltrombopag on platelet counts and bleeding during treatment of chronic idiopathic thrombocytopenic purpura: a randomised, double-blind, placebo-controlled trial
James B. Bussel et al.
LANCET (2009)
Historical review. The light and shadow of Paul Kaznelson: his life and contribution to hematology
Yataro Yoshida
ANNALS OF HEMATOLOGY (2008)
Analysis of regulatory T-cell changes in patients with idiopathic thrombocytopenic purpura receiving B cell-depleting therapy with rituximab
Roberto Stasi et al.
BLOOD (2008)
Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura:: a double-blind randomised controlled trial
David J. Kuter et al.
LANCET (2008)
Activity and safety profile of low-dose rituximab for the treatment of autoimmune cytopenias in adults
Drew Provan et al.
HAEMATOLOGICA (2007)
Eltrombopag for the treatment of chronic idiopathic thrombocytopenic purpura
James B. Bussel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Phase 1 clinical study of eltrombopag, an oral, nonpeptide thrombopoietin receptor agonist
Julian M. Jenkins et al.
BLOOD (2007)
Therapy with high-dose dexamethasone (HD-DXM) in previously untreated patients affected by idiopathic thrombocytopenic purpura: a GIMEMA experience
Maria Gabriella Mazzucconi et al.
BLOOD (2007)
Systematic review: Efficacy and safety of rituximab for adults with idiopathic thrombocytopenic purpura
Donald M. Arnold et al.
ANNALS OF INTERNAL MEDICINE (2007)
An open-label, unit dose-finding study of AMG 531, a novel thrombopoiesis-stimulating peptibody, in patients with immune thrombocytopenic purpura
Adrian Newland et al.
BRITISH JOURNAL OF HAEMATOLOGY (2006)
AMG 531, a thrombopoiesis-stimulating protein, for chronic ITP
James B. Bussel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Response to splenectomy is durable after a certain point in time in adult patients with chronic immune thrombocytopenic purpura
Eva Johansson et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2006)
Efficacy of mycophenolate mofetil as single-agent therapy for refractory immune thrombocytopenic purpura
D Provan et al.
AMERICAN JOURNAL OF HEMATOLOGY (2006)
Efficacy of mycophenolate mofetil in adult refractory auto-immune cytopenias: a single center preliminary study
R Kotb et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2005)
Discovery and characterization of a selective, nonpeptidyl thrombopoietin receptor agonist
CL Erickson-Miller et al.
EXPERIMENTAL HEMATOLOGY (2005)
Management of immune thrombocytopenic purpura in adults
R Stasi et al.
MAYO CLINIC PROCEEDINGS (2004)
The efficacy and safety of B-cell depletion with anti-CD20 monoclonal antibody in adults with chronic immune thrombocytopenic purpura
N Cooper et al.
BRITISH JOURNAL OF HAEMATOLOGY (2004)
Management of adult patients with persistent idiopathic thrombocytopenic purpura following splenectomy - A systematic review
SK Vesely et al.
ANNALS OF INTERNAL MEDICINE (2004)
Long-term outcomes in adults with chronic ITP after splenectomy failure
R McMillan et al.
BLOOD (2004)
Pharmacodynamics and pharmacokinetics of AMG 531, a novel thrombopoietin receptor ligand
B Wang et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2004)
Splenectomy for adult patients with idiopathic thrombocytopenic purpura: a systematic review to assess long-term platelet count responses, prediction of response, and surgical complications
K Kojouri et al.
BLOOD (2004)
Danazol therapy in patients with chronic idiopathic thrombocytopenic purpura:: Long-term results
F Maloisel et al.
AMERICAN JOURNAL OF MEDICINE (2004)
Clinically significant newly presenting autoimmune thrombocytopenic purpura in adults: a prospective study of a population-based cohort of 245 patients
AJ Neylon et al.
BRITISH JOURNAL OF HAEMATOLOGY (2003)
Long term follow-up after splenectomy performed for immune thrombocytopenic purpura (ITP)
J Schwartz et al.
AMERICAN JOURNAL OF HEMATOLOGY (2003)
Laparoscopic splenectomy for immune thrombocytopenic purpura in patients with severe refractory thrombocytopenia
A Keidar et al.
PATHOPHYSIOLOGY OF HAEMOSTASIS AND THROMBOSIS (2003)
Fifty years of idiopathic thrombocytopenic purpura (ITP): Management of refractory ITP in adults
D Provan et al.
BRITISH JOURNAL OF HAEMATOLOGY (2002)
To the editor: Variable patterns of response to rituximab treatment in adults with chronic idiopathic thrombocytopenic purpura
R Stasi et al.
BLOOD (2002)
Does treatment with intermittent infusions of intravenous anti-D allow a proportion of adults with recently diagnosed immune thrombocytopenic purpura to avoid splenectomy?
N Cooper et al.
BLOOD (2002)
Long-term salvage therapy with cyclosporin A in refractory idiopathic thrombocytopenic purpura
G Emilia et al.
BLOOD (2002)
Hydrazinonaphthalene and azonaphthalene thrombopoietin mimics are nonpeptidyl promoters of megakaryocytopoiesis
KJ Duffy et al.
JOURNAL OF MEDICINAL CHEMISTRY (2001)
Cyclosporin A for the treatment of patients with chronic idiopathic thrombocytopenic purpura refractory to corticosteroids or splenectomy
MC Kappers-Klunne et al.
BRITISH JOURNAL OF HAEMATOLOGY (2001)
Do the acute platelet responses of patients with immune thrombocytopenic purpura (ITP) to IV anti-D and to IV gammaglobulin predict response to subsequent splenectomy?
JB Bussel et al.
AMERICAN JOURNAL OF HEMATOLOGY (2001)
Morbidity and mortality in adults with idiopathic thrombocytopenic purpura
JEA Portielje et al.
BLOOD (2001)
The bleeding risk and natural history of idiopathic thrombocytopenic purpura in patients with persistent low platelet counts
YC Cohen et al.
ARCHIVES OF INTERNAL MEDICINE (2000)
Share Paper
